US8962594B2 - Method of Using Nutritional Compounds Dihydroquercetin (taxifolin) and Arabinogalactan in Combination with Dihydroquercetin (taxifolin) to Reduce and Control Cardiometabolic Risk Factors Associated with Metabolic Syndrome and Hypercholesterolemia